Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-003995
Filing Date
2021-02-01
Accepted
2021-02-01 21:45:42
Documents
2
Period of Report
2021-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6667
2 EX-24 DOCUMENT attachment1.htm EX-24 4446
  Complete submission text file 0000899243-21-003995.txt   12470
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address
Callori Fred (Reporting) CIK: 0001843393 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37467 | Film No.: 21578771